Optimal Time for MRI Scanning of Tumors in BALB/c Mice Using c-erbB2 Antisense Probe Labeled with Superparamagnetic Iron Oxide Nanoparticles

WEN Zhi-peng, LIU Hai-yan, WEN Ming, HE Hai-rong, TAN Shu-de, LI Shao-lin

Abstract

To determine the optimal time for MRI scanning of tumors in BALB/c mice using c-erbB2 antisense probe labeled with superparamagnetic iron oxide nanoparticles. Methods SK-Br-3 tumor-bearing BALB/c mice (n=30) were injected with antisense probe (12.0 mg Fe/kg). MRI scanning was performed on 5 mice before the injection and 60 min,180 min,360 min,720 min and 1 440 min after the injection, respectively. Tumor tissues were taken immediately after the scanning and fixed with 10% formalin and paraffin-embedded sections. The MRI signal strength of the tumors and adjacent muscles were compared with changes detected under a microscope using HE and Prussian blue staining. Results SK-Br-3 tumors were introduced to the BALB/c mice successfully. The strongest signal intensity was detected by the MRI 360 min after injection with the antisense probe. The pathological examination revealed structural disorders of the tumor issues, with a large number of special-shaped cells arranged in a cancer nest shape. Punctuate blue iron particles were observed in all of the tumor issues, with the greatest density occurring at 360 min after the injection with the antisense probe. Conclusion The optimal time for MRI scanning of tumors in BALB/c mice using c-erbB2 antisense probe labeled with superparamagnetic iron oxide nanoparticles should be set at 360 min after injection.

 

Keywords: Superparamagnetic iron oxide, Antisense probe, Live animal, MR imaging, Scan time

 

Full Text:

PDF


References


Wen M, Li В, Bai W, et al. Application of atomic force microscopy in morphological observation of antisense probe labeled with magnetism. Mol Vis,2008; 14( 1): 114-117.

Wen M, Li B, Ouyang Y. et al. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study. Ann Biomed Eng.2009;37(6): 1240-1250.

Shi X, Wang SH, Swanson SD, et al. Dendrimer- functionalized shell-crosslinked iron oxide nanoparticles for in- vivo magnetic resonance imaging of tumors. Adv Mater,2008; 20(2):1671-1678.

Lin MM, Kim HH, Kim H, et al. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy. Nanomedicine,2010;5( 1); 109-133.

Li X, Du X. Huo Т, et al. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3. 0-Tesla magnetic resonance scanner. Acta Radiol,2009;50(6);583-594.

Chen K. Chen X. Design and development of molecular imaging probes. Curr Top Med Chem, 2010; 10 ( 12 ); 1227- 1236.


Refbacks

  • There are currently no refbacks.